Pelage Pharmaceuticals, Inc.

CIK 1982875 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Pelage Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 24, 2025D0001982875-25-000002
Aug 23, 2024D0001982875-24-000002
Jun 28, 2023D0001982875-23-000001